KLK3 and urogenital neoplasm: The only available blood test for PCa in widespread clinical use involves measuring circulating levels of PSA (at 4 ng/ml has 21% sensitivity and 93% specificity, PCa prevention trial) [7], however, the prostate size, benign prostatic hyperplasia and prostatitis may also increase PSA levels.